Selection of blockbuster announcements

1. Great Wall Motor: the net profit of returning to his mother reached 8.279 billion yuan in 2022, which is firmly determined to transform global intelligent technology companies.

$GREATWALL MOTOR (02333.HK)$KuaiBao announced its annual results in 2022. In 2022, the company's total operating income was 137.351 billion yuan (RMB, the same as below), an increase of 0.69% over the same period last year; the net profit attributable to shareholders was 8.279 billion yuan, up 23.09% from the same period last year; net profit belonging to shareholders after deducting non-recurring profits and losses was 4.536 billion yuan, an increase of 7.14% over the same period last year; basic earnings per share was 0.91 yuan. The year-on-year increase in net profit attributed to the company's shareholders during the reporting period was mainly due to the company's increased production capacity, increased profitability of vehicle models, and increased exchange rate earnings. During the reporting period, Great Wall Motor firmly believes in the transformation of global intelligent technology companies, focusing on electrification, intelligent technological innovation and global development, deepening user operation, and improving system strength and ecological construction.

2. Yingxi of China ship Leasing: the profit attributable to equity holders is expected to increase by 24% 26%.

$CSSC (03877.HK)$According to the announcement, it is expected that for the year ended December 31, 2022, the group's earnings (unaudited) will increase by about 30% compared with 2021, and the profit attributable to group equity holders (unaudited) will increase by 24%, 26% over 2021, reaching the best level since the establishment of the company.

INNOVENT BIO's total product income in the fourth quarter is about 1 billion yuan.

$INNOVENT BIO (01801.HK)$It was announced that in the fourth quarter of 2022, the company made a total product income of about 1 billion yuan. Due to the spread of the COVID-19 epidemic across the country in the fourth quarter, the company's product sales and promotion activities in the national market were affected to a certain extent. But at the same time, the impact was partly offset by the continued contribution of new products and the official entry of Xilanxue (Ramoxiu) into the market in the fourth quarter.

4. Cornerstone Pharmaceutical-B issued a positive profit forecast: the total revenue in 2022 is expected to be no less than 475 million yuan, an increase of about 100% over the same period last year.

$CSTONE PHARMA-B (02616.HK)$Revenue in 2022 is expected to be no less than 475 million yuan, an increase of about 100% over the same period last year, and the annual loss is expected to be no more than 800 million yuan, 53% smaller than that of the same period in 2021. Mainly because the listed products began to contribute revenue.

5. Aoneng Construction: reaching strategic cooperation with GSS Energy on the development of electric vehicle business in Southeast Asia

$MECOM Power and Construction (01183.HK)$According to the announcement, on February 2, 2023, Australia and GSS Energy entered into a non-binding letter of intent. According to the binding document, Australia and GSS Energy are required to reach a strategic cooperation on the development of electric vehicle business in Singapore, Thailand, Indonesia and Malaysia for a period of 3 years, starting from the date of the letter of intent, unless it is terminated by a separate written agreement with GSS Energy within the time limit.

6. Fuhong Hanlin: HLX07 (Recombinant Anti-EGFR humanized Monoclonal Antibody injection) combined with chemotherapy in the treatment of advanced solid tumor phase 1b/2 clinical study showed that it was safe and well tolerated.

$HENLIUS-B (02696.HK)$Recently, the company independently developed HLX07 (Recombinant Anti-EGFR humanized Monoclonal Antibody injection) ("HLX07") combined chemotherapy has completed a phase 1b/2 clinical study in China (except Hong Kong, Macao and Taiwan, the same below), which has shown good safety and tolerance in a phase 1b/2 clinical study conducted in patients with advanced solid tumors.

Performance forecast

Cornerstone Pharmaceutical-B (02616) issued a positive profit forecast: total revenue is expected to be no less than 475 million yuan in 2022, almost double that of the same period last year.

Kwong Wenji (08023) Ying Xi: profit in the first three quarters is expected to rise by about 260%

Chuanghui Jewelry (08537) profit is expected to be about HK $2.1 million in the first three quarters, turning losses into profits compared with the same period last year.

China Longgong (03339): the net profit is expected to be between 320 million yuan and 450 million yuan, a decrease of 64.72% to 74.91% compared with the same period last year.

Tianhong International Group (02678): the net profit is expected to decrease by more than 90% compared with the same period last year.

China Longgong (03339) earnings warning: expected annual net profit decreased by 64.72% to 74.91%

Kingway Medical (08143) profit Police: estimated loss of HK $10.5 million in the first nine months

China Science and Technology Industry Group (08111): the loss attributable to the owner of the company is expected to be about 2.9 million yuan in the first September.

Earth Education (08417): expected net loss of about HK $9.8 million in the first nine months

Important matters

Shunfeng Tongcheng (09699): 78.9477 million domestic unlisted shares are expected to be converted into H shares on February 6th.

Digital Kingdom (00547): complete the allotment and issue of 146 million subscription shares and 73.125 million subscription shares to subscribers An and B on February 2 at a subscription price of HK $0.32 per share

Assets under the name of Lasha Taicang, a wholly-owned subsidiary of Lashabel (06116), will be put up for judicial auction.

Equity reorganization

Jinzhou Bank (00416): major shareholders in China intend to implement a package of financial restructuring transactions for Jinzhou Bank.

Investment and operation

Jiamin Group (08519): Hong Kong Airport Duddell Club resumes operation

Fu Hong Hanlin (02696): HLX07 (Recombinant Anti-EGFR humanized Monoclonal Antibody injection) combined with chemotherapy in the treatment of advanced solid tumor phase 1b/2 clinical study showed that it was safe and well tolerated.

Aoneng Construction (01183): sign a letter of intent on strategic cooperation in electric vehicle business in Southeast Asia

CSC FINANCIAL CO.,LTD (06066): self-employed participation in carbon emissions trading received a letter from the China Securities Regulatory Commission

La Chabel (06116): the court ordered the auction of real estate and ground attachments owned by Lasha Taicang at 116Guangzhou East Road, Taicang City.

Repurchase cancellation

AIA Group Limited (01299) spent HK $225 million to buy back 2.6138 million shares on February 2nd.

Yum China (09987) spent US $1 million to buy back 16200 shares on February 1st.

Hisense Home Appliances (00921) spent 13.244 million yuan on February 2 to buy back 780600 A shares

Sunshine Paper (02002) spent HK $1.7948 million to buy back 840000 shares on February 2nd

ESR Cayman Limited (01821) spent HK $4.0769 million to buy back 250000 shares on February 2nd.

Debt financing

Cosco Haifa (02866) intends to issue no more than 8 billion yuan of corporate bonds

Edit / irisz